These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 6161341)
21. Aspects of the action of novobiocin on Staphylococcus aureus and Bacillus megaterium. Morris A; Russell AD Microbios; 1971 Jan; 3(9):33-41. PubMed ID: 5005820 [No Abstract] [Full Text] [Related]
22. Mechanisms of action of acriflavine: electron microscopic study of cell wall changes induced in Staphylococcus aureus by acriflavine. Kawai M; Yamagishi J Microbiol Immunol; 2009 Sep; 53(9):481-6. PubMed ID: 19703241 [TBL] [Abstract][Full Text] [Related]
23. [Vancomycin resistant Staphylococcus aureus. Feared for a long time, reality now!]. Nielsen L; Westh H; Kolmos HJ Ugeskr Laeger; 1998 Aug; 160(32):4655-6. PubMed ID: 9719751 [No Abstract] [Full Text] [Related]
29. Induced resistance to the antimicrobial peptide lactoferricin B in Staphylococcus aureus. Samuelsen O; Haukland HH; Jenssen H; Krämer M; Sandvik K; Ulvatne H; Vorland LH FEBS Lett; 2005 Jun; 579(16):3421-6. PubMed ID: 15946666 [TBL] [Abstract][Full Text] [Related]
30. [Efflux pumps: their role in Staphylococcus aureus antibiotic resistance]. Doléans-Jordheim A; Michalet S; Bergeron E; Boisset S; Souard F; Dumontet C; Dijoux-Franca MG; Freney J Ann Biol Clin (Paris); 2008; 66(5):499-508. PubMed ID: 18957338 [TBL] [Abstract][Full Text] [Related]
31. [Action mechanism of antibiotics]. Schrinner E Dtsch Med J; 1971 Oct; 22(20):647-52. PubMed ID: 5120334 [No Abstract] [Full Text] [Related]
32. The biochemical basis of antimicrobial and bacterial resistance. Neu HC Bull N Y Acad Med; 1987 Apr; 63(3):295-317. PubMed ID: 3300829 [No Abstract] [Full Text] [Related]
33. The bacterial envelope as a target for novel anti-MRSA antibiotics. Van Bambeke F; Mingeot-Leclercq MP; Struelens MJ; Tulkens PM Trends Pharmacol Sci; 2008 Mar; 29(3):124-34. PubMed ID: 18262289 [TBL] [Abstract][Full Text] [Related]
34. Oleoyl-chitosan nanoparticles inhibits Escherichia coli and Staphylococcus aureus by damaging the cell membrane and putative binding to extracellular or intracellular targets. Xing K; Chen XG; Liu CS; Cha DS; Park HJ Int J Food Microbiol; 2009 Jun; 132(2-3):127-33. PubMed ID: 19439383 [TBL] [Abstract][Full Text] [Related]
35. Mechanisms of action of antimicrobial agents. Sanders E; Cluff LE Pediatr Clin North Am; 1968 Feb; 15(1):3-11. PubMed ID: 4866905 [No Abstract] [Full Text] [Related]
36. Clinical use of combinations of antimicrobial agents. McCabe WR Antimicrob Agents Chemother (Bethesda); 1967; 7():225-33. PubMed ID: 5596143 [No Abstract] [Full Text] [Related]
37. Structural biological study of self-resistance determinants in antibiotic-producing actinomycetes. Sugiyama M J Antibiot (Tokyo); 2015 Sep; 68(9):543-50. PubMed ID: 25873321 [TBL] [Abstract][Full Text] [Related]
38. The mode of action of novobiocin. Morris A; Russell AD Prog Med Chem; 1971; 8(1):39-59. PubMed ID: 4254750 [No Abstract] [Full Text] [Related]
39. [Complications in antibiotic therapy]. Bergström I Tidskr Sver Sjukskot; 1968 May; 9():458-63. PubMed ID: 5186634 [No Abstract] [Full Text] [Related]
40. [Complications in antibiotic therapy]. Bergström I Tidskr Sver Sjukskot; 1968 May; 35(9):458-63. PubMed ID: 5189710 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]